Troutman Sanders has both the experience and knowledge to guide our life sciences clients through the complex and highly regulated challenges of business competition and antitrust issues in the U.S., as well as abroad. We regularly advocate for clients before enforcement agencies such as the Department of Justice and the Federal Trade Commission, as well as before foreign agencies, including the European Commission. Our lawyers are skilled on current antitrust laws and regulations and work with our clients to ensure proper compliance and avoid litigation by preparing antitrust audits, compliance programs, and employee training programs. We have particular experience advising clients on pricing and distribution issues in the life sciences sector and have successfully handled abbreviated new drug applications (ANDAs) and related litigation.
Government Investigations, Compliance and Enforcement
Our White Collar and Government Investigations lawyers have a wealth of experience in successfully representing our clients, both corporations and individuals, in complex federal and state criminal investigations; government agency investigations, including SEC enforcement and DOJ enforcement actions under the False Claims Act; internal investigations; and civil or regulatory proceedings, both in jurisdictions across the United States and numerous countries abroad.
Our lawyers also provide global Foreign Corrupt Practices Act (FCPA) counseling and anti-corruption investigative experience to our clients. We focus on the delivery of comprehensive, results-oriented FCPA enforcement prevention, risk mitigation, and defense solutions. We have represented U.S. and non-U.S. companies and international entities before the DOJ, SEC and other government agencies, in connection with FCPA and related anti-bribery matters, as well as whistleblower complaints under the Dodd-Frank Wall Street Reform and Consumer Protection Act. We have handled third-party and merger and acquisition-related anti-bribery due diligence reviews and opinions, and related DOJ and SEC representations.